Profil
Marc B. Blaustein is the founder of Akashi Therapeutics Inc, which was founded in 2011.
He held the title of Chief Executive Officer from 2011 to 2017.
Mr. Blaustein's former jobs include being the Chief Executive Officer of Ned Biosystems, Inc. from 2017 to 2019, Head of Business Development at Genetics Institute LLC, Senior Vice President of Manufacturing, Process & Commercial Operations at Dyax Corp.
from 2006 to 2009, Chief Operating, Financial & Accounting Officer at Finch Therapeutics Group, Inc. from 2022 to 2023, and Head of Business Development at Guide Therapeutics, Inc. from 2019 to 2021.
He is also a Founding Partner at Northbridge Consulting.
Mr. Blaustein's education includes a graduate degree from Harvard University and an undergraduate degree from the University of Pennsylvania.
Anciens postes connus de Marc Blaustein
| Sociétés | Poste | Fin |
|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Directeur Financier/CFO | 15/05/2023 |
Guide Therapeutics, Inc.
Guide Therapeutics, Inc. BiotechnologyHealth Technology Develops biophotonic technology platform for the early detection of disease that leads to cancer | Corporate Officer/Principal | 01/01/2021 |
Ned Biosystems, Inc.
Ned Biosystems, Inc. BiotechnologyHealth Technology Develops proprietary combination cancer therapies | Directeur Général | 01/01/2019 |
Akashi Therapeutics Inc
Akashi Therapeutics Inc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Directeur Général | 01/01/2017 |
| DYAX CORP. | Corporate Officer/Principal | 01/01/2009 |
Formation de Marc Blaustein
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Dyax Corp.
Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akashi Therapeutics Inc
Akashi Therapeutics Inc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
Ned Biosystems, Inc.
Ned Biosystems, Inc. BiotechnologyHealth Technology Develops proprietary combination cancer therapies | Health Technology |
Finch Therapeutics Group, Inc.
Finch Therapeutics Group, Inc. Medical/Nursing ServicesHealth Services Provides microbial therapy services | Health Services |
Guide Therapeutics, Inc.
Guide Therapeutics, Inc. BiotechnologyHealth Technology Develops biophotonic technology platform for the early detection of disease that leads to cancer | Health Technology |
Northbridge Consulting |
















